SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer

por Li, Ming, Li, Anqi, Zhou, Shuling, Lv, Hong, Yang, Wentao
Publicado 2019

Carbohydrate response element binding protein (ChREBP) correlates with colon cancer progression and contributes to cell proliferation

por Lei, Yu, Zhou, Shuling, Hu, Qiaoling, Chen, Xueling, Gu, Jiang
Publicado 2020

Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma

por Chen, Wei, Shan, Boer, Zhou, Shuling, Yang, Huijuan, Ye, Shuang
Publicado 2022

Recurrence Patterns and Survival Outcomes in Chinese Patients with Surgically Treated Recurrent Ovarian Clear Cell Carcinoma: A Single Institutional Analysis of 45 Cases

por Ye, Shuang, Zhou, Shuling, Chen, Wei, Xiang, Libing, Wu, Xiaohua, Yang, Huijuan
Publicado 2020

The role of [Formula: see text] F-FDG PET/CT-based quantitative metabolic parameters in patients with ovarian clear cell carcinoma

por Ye, Shuang, Liu, Shuai, Zhou, Shuling, Xiang, Libing, Wu, Xiaohua, Yang, Huijuan
Publicado 2020

HER2-low breast cancer: evolution of HER2 expression from primary tumor to distant metastases

por Cai, Mengyuan, Li, Ming, Lv, Hong, Zhou, Shuling, Xu, Xiaoli, Shui, Ruohong, Yang, Wentao
Publicado 2023

HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer

por Li, Anqi, Liu, Zebing, Li, Ming, Zhou, Shuling, Xu, Yan, Xiao, Yaoxing, Yang, Wentao
Publicado 2016

Correction: HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer

por Li, Anqi, Liu, Zebing, Li, Ming, Zhou, Shuling, Xu, Yan, Xiao, Yaoxing, Yang, Wentao
Publicado 2017

Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer

por Li, Ming, Li, Anqi, Zhou, Shuling, Xu, Yan, Xiao, Yaoxing, Bi, Rui, Yang, Wentao
Publicado 2018

Differential expression and clinical significance of epithelial-mesenchymal transition markers among different histological types of triple-negative breast cancer

por Zhou, Shuling, Sun, Xiangjie, Yu, Lin, Zhou, Ruoji, Li, Anqi, Li, Ming, Yang, Wentao
Publicado 2018

Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications

por Chen, Wei, Zhong, Siyuan, Shan, Boer, Zhou, Shuling, Wu, Xiaohua, Yang, Huijuan, Ye, Shuang
Publicado 2020

Data-driven evaluation and optimization of the sustainable development of the logistics industry: case study of the Yangtze River Delta in China

por Ding, Heping, Liu, Yujia, Zhang, Yingyan, Wang, Shuxia, Guo, Yuxia, Zhou, Shuling, Liu, Conghu
Publicado 2022

Comparison of clinicopathological characteristics and response to neoadjuvant chemotherapy between HER2-low and HER2-zero breast cancer

por Zhou, Shuling, Liu, Ting, Kuang, Xiaying, Zhen, Tiantian, Shi, Huijuan, Lin, Ying, Shao, Nan
Publicado 2022

Role of BC040587 as a predictor of poor outcome in breast cancer

por Chi, Yayun, Huang, Sheng, Yuan, Lin, Liu, Mengying, Huang, Naisi, Zhou, Shuling, Zhou, Bingqing, Wu, Jiong
Publicado 2014

The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma

por Ye, Shuang, Zhou, Shuling, Zhong, Siyuan, Shan, Boer, Jiang, Wenhua, Yang, Wentao, Cai, Xu, Yang, Huijuan
Publicado 2022

Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis

por Vanden Heuvel, John P., Zhou, Shuling, Patel, Anisha B., Kamerow, Harry N., Baran, Peter, Ford, John P.
Publicado 2023

Low frequency of BRAF and KRAS mutations in Chinese patients with low-grade serous carcinoma of the ovary

por Xu, Yan, Bi, Rui, Xiao, Yaoxing, Tu, Xiaoyu, Li, Ming, Li, Anqi, Shan, Ling, Zhou, Shuling, Yang, Wentao
Publicado 2017

A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China

por Zhou, Shuling, Lv, Hong, Li, Anqi, Li, Ming, Zhong, Siyuan, Lu, Hongfen, Zhou, Xiaoyan, Bai, Qianming, Yang, Wentao
Publicado 2023

Transient p53 Suppression Increases Reprogramming of Human Fibroblasts without Affecting Apoptosis and DNA Damage

por Rasmussen, Mikkel A., Holst, Bjørn, Tümer, Zeynep, Johnsen, Mads G., Zhou, Shuling, Stummann, Tina C., Hyttel, Poul, Clausen, Christian
Publicado 2014

Effects of caloric overload before caloric restriction in the murine heart

por Maldonado, Martin, Chen, Jianying, Duan, Huiqin, Zhou, Shuling, Yang, Lujun, Raja, Mazhar Ali, Huang, Tianhua, Jiang, Gu, Zhong, Ying
Publicado 2022